Amy Alford, MA

Amy Alford, MA, has extensive work experience in the field of clinical operations, research, and development. Amy is currently serving as the Vice President of Research & Development Operations at Senti Biosciences since March 2023. Prior to this, they held the position of Vice President of Clinical Strategy & Operations at the same company starting in April 2022. From July 2021 to March 2022, Amy worked as the Senior Director of Clinical Operations at Kronos Bio, Inc. Before that, they held the role of Director of Clinical Operations at Senti Biosciences from September 2019 to September 2020. Amy also gained valuable experience at Peloton Therapeutics as the Associate Director of Clinical Operations (acquired by Merck) from April 2019 to September 2019, and as a Contract Clinical Operations specialist from November 2016 to March 2019. Prior to these roles, they owned and acted as a Clinical Research Consultant for Mountain Vista Clinical Research Consulting, LLC from April 2013 to March 2019. Amy's earlier experience includes working as an Associate Manager of Clinical Operations at Reata Pharmaceuticals from May 2011 to April 2013, a Clinical Research Associate at Reata Pharmaceuticals from March 2010 to April 2011, and a Senior Clinical Research Associate at Quintiles, Inc from May 2006 to March 2010. Amy began their career as a Senior Clinical Research Coordinator at Emory University from May 2003 to May 2006. Overall, Amy has had a diverse and progressive career in clinical operations and research, with expertise in strategy development, execution, and management.

Amy Alford holds a Master of Arts (MA) degree in Clinical, Counseling and Applied Psychology from Northwestern University. Prior to obtaining their MA, they completed their Bachelor of Arts (BA) degree in Biology & Psychology at Rhodes College. The specific start and end dates for each educational experience were not provided.